Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Central European Leukemia Study Group.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Central European Leukemia Study Group
ClinicalTrials.gov Identifier:
NCT00327262
First received: May 16, 2006
Last updated: June 16, 2006
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2008
  Estimated Primary Completion Date: No date given
No publications provided by Central European Leukemia Study Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):